These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9729096)

  • 1. Neonatal screening for cystic fibrosis. Early diagnosis is important to parents even if it makes little difference to outcome.
    Pollitt R
    BMJ; 1998 Aug; 317(7155):411-2. PubMed ID: 9729096
    [No Abstract]   [Full Text] [Related]  

  • 2. A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program.
    Doull IJ; Hall SJ; Bradley DM
    Pediatr Pulmonol; 2007 Sep; 42(9):773-8. PubMed ID: 17659601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for cystic fibrosis. Early diagnosis allows option of prenatal diagnosis in subsequent pregnancies.
    Lane B; Harris R; Harris H
    BMJ; 1998 Aug; 317(7155):411. PubMed ID: 9729095
    [No Abstract]   [Full Text] [Related]  

  • 4. Nasal potential difference in cystic fibrosis diagnosis of very young children.
    Sermet-Gaudelus I; Girodon E; Huet F; Aboutaam R; Bui S; Deneuville E; Guillot M; Vrielynck S; Lenoir G; Edelman A
    J Pediatr; 2007 Mar; 150(3):e34-5. PubMed ID: 17307527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and neonatal screening of cystic fibrosis].
    Roussey M; Deneuville E; Dabadie A
    Rev Prat; 2003 Jan; 53(2):135-40. PubMed ID: 12664843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J; Clements B;
    Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM
    Adv Pediatr; 2000; 47():79-115. PubMed ID: 10959441
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
    Comeau AM; Accurso FJ; White TB; Campbell PW; Hoffman G; Parad RB; Wilfond BS; Rosenfeld M; Sontag MK; Massie J; Farrell PM; O'Sullivan BP;
    Pediatrics; 2007 Feb; 119(2):e495-518. PubMed ID: 17272609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental support for newborn screening for cystic fibrosis.
    de Monestrol I; Brucefors AB; Sjöberg B; Hjelte L
    Acta Paediatr; 2011 Feb; 100(2):209-15. PubMed ID: 20950284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes.
    Campbell PW; White TB
    J Pediatr; 2005 Sep; 147(3 Suppl):S2-5. PubMed ID: 16202776
    [No Abstract]   [Full Text] [Related]  

  • 14. The meaning of "early" diagnosis in a new era of cystic fibrosis care.
    Farrell PM
    Pediatrics; 2007 Jan; 119(1):156-7. PubMed ID: 17200282
    [No Abstract]   [Full Text] [Related]  

  • 15. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
    Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM
    Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal screening for cystic fibrosis: a new screening program and a new challenge].
    Farriaux JP
    Ann Biol Clin (Paris); 2002; 60(1):13-4. PubMed ID: 11830390
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neonatal screening of cystic fibrosis: which benefits?].
    Brouard J; Laurans M; Arion A; Kauffmann D; Sevin I; Laroche D; Travert G; Duhamel JF
    Arch Pediatr; 2005 Jun; 12(6):643-5. PubMed ID: 15904756
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neonatal screening for cystic fibrosis].
    Gartner S; Cobos N
    An Pediatr (Barc); 2009 Dec; 71(6):481-2. PubMed ID: 19926040
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating the annual number of false negative cystic fibrosis newborn screening tests.
    Fritz A; Farrell P
    Pediatr Pulmonol; 2012 Feb; 47(2):207-8. PubMed ID: 22081583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.